Literature DB >> 26031324

Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experience.

Shinji Itoh1, Ken Shirabe1, Tomoharu Yoshizumi1, Kazuki Takeishi1, Norifumi Harimoto1, Toru Ikegami1, Hirofumi Kawanaka1,2, Akihiro Nishie3, Takahide Kamishima4, Yoshihiko Maehara1.   

Abstract

AIM: We aimed to evaluate whether skeletal muscle mass measured by computed tomography (CT) or bioelectrical impedance analysis (BIA) correlated to muscle strength and physical performance in liver-related hospital cases.
METHODS: We prospectively conducted this study in 120 liver-related hospital cases. Skeletal muscle mass was measured by CT scan and BIA. Muscle strength was determined by hand grip strength and physical performance by usual gait speed.
RESULTS: Skeletal muscle mass measured using CT significantly correlated to usual gait speed (r(2)  = 0.17, P < 0.0001) and hand grip strength (r(2)  = 0.66, P < 0.0001), but the correlations were lower using BIA (r(2)  = 0.1, P = 0.0005; r(2)  = 0.54, P < 0.0001). With regard to liver function, the relationship between skeletal muscle mass measured by CT and BIA and two muscle function parameters in the Child-Pugh A group were significant. In contrast, skeletal muscle mass measured by BIA in the Child-Pugh B or C group was not significantly related to usual gait speed.
CONCLUSION: Skeletal muscle mass measured by CT was significantly correlated to hand grip strength and usual gait speed, with higher correlations compared with BIA. Moreover, skeletal muscle mass measured by CT significantly correlated with two muscle functions, even in patients with Child-Pugh B or C.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  muscle strength; physical performance; skeletal muscle mass

Year:  2015        PMID: 26031324     DOI: 10.1111/hepr.12537

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

Review 1.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

2.  The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).

Authors:  Yoshinao Kobayashi; Nagisa Hara; Ryosuke Sugimoto; Rumi Mifuji-Moroka; Hideaki Tanaka; Akiko Eguchi; Motoh Iwasa; Hiroshi Hasegawa; Kazuko Iwata; Yoshiyuki Takei; Osamu Taguchi
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

3.  Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.

Authors:  Shigeki Bamba; Masaya Sasaki; Azusa Takaoka; Kenichiro Takahashi; Hirotsugu Imaeda; Atsushi Nishida; Osamu Inatomi; Mitsushige Sugimoto; Akira Andoh
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

4.  Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.

Authors:  Atsushi Hiraoka; Hirofumi Izumoto; Hidetaro Ueki; Takeaki Yoshino; Toshihiko Aibiki; Tomonari Okudaira; Hiroka Yamago; Yoshifumi Suga; Ryuichiro Iwasaki; Hideomi Tomida; Kenichiro Mori; Hideki Miyata; Eiji Tsubouchi; Masato Kishida; Tomoyuki Ninomiya; Masashi Hirooka; Masanori Abe; Bunzo Matsuura; Yoichi Hiasa; Kojiro Michitaka
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02-21       Impact factor: 12.910

5.  Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease.

Authors:  Kazuki Ohashi; Toru Ishikawa; Asami Hoshii; Tamaki Hokari; Mitsuyuki Suzuki; Yuta Mitobe; Etsuko Yamada; Hansani Madushika Abeywickrama; Yuko Kikuchi; Hirohito Noguchi; Hiroshi Hirosawa; Yu Koyama
Journal:  J Clin Med Res       Date:  2019-10-04

6.  Deficiency, incapacity and social disadvantage of patients with chronic hepatitis B: a case-control study.

Authors:  Jihene Bergaoui; Imed Latiri; Helmi Ben Saad
Journal:  Tunis Med       Date:  2021 Juillet

7.  Progressive loss of muscle mass could be an adverse prognostic factor of 28-day mortality in septic shock patients.

Authors:  Dong-Woo Seo; Kyung Won Kim; Chang Hwan Sohn; Seung Mok Ryoo; Youn-Jung Kim; Ahn Shin; Won Young Kim
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.